Overview

Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

Status:
NOT_YET_RECRUITING
Trial end date:
2025-07-30
Target enrollment:
Participant gender:
Summary
Exploring and evaluating the efficacy of herombopag in preventing thrombocytopenia due to radiotherapy for cervical cancer
Phase:
PHASE2
Details
Lead Sponsor:
Peking University Cancer Hospital & Institute